Tissue Regenix Group plc (LON:TRX – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 43.64 ($0.60) and traded as low as GBX 29 ($0.40). Tissue Regenix Group shares last traded at GBX 29.05 ($0.40), with a volume of 51,597 shares trading hands.
Tissue Regenix Group Stock Performance
The company has a market capitalization of £26.15 million, a PE ratio of -29.94 and a beta of 1.61. The business’s 50-day moving average is GBX 32.62 and its 200-day moving average is GBX 43.64. The company has a debt-to-equity ratio of 31.16, a quick ratio of 2.36 and a current ratio of 4.03.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Read More
- Five stocks we like better than Tissue Regenix Group
- Election Stocks: How Elections Affect the Stock Market
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- How to Short Nasdaq: An Easy-to-Follow Guide
- Is IBM’s AI Transformation Powering a Sustained Rally?
- Most active stocks: Dollar volume vs share volume
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.